TNF Pharmaceuticals (TNFA) and Its Rivals Financial Survey
Risk & Volatility TNF Pharmaceuticals has a beta of 2.13, indicating that its stock price is 113% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals’ competitors have a beta of 1.29, indicating that their average stock price is 29% more volatile than the S&P 500. Institutional and Insider Ownership 9.6% of TNF Pharmaceuticals shares […]
Risk & Volatility TNF Pharmaceuticals has a beta of 2.13, indicating that its stock price is 113% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals’ competitors have a beta of 1.29, indicating that their average stock price is 29% more volatile than the S&P 500. Institutional and Insider Ownership 9.6% of TNF Pharmaceuticals shares […]
